• Home
  • About Us
  • Blog

Pulmonary Hypertension RN

  • What is Pulmonary Hypertension?
    • What is Pulmonary Hypertension?
    • Pulmonary Hypertension Symptoms
    • Types of Pulmonary Hypertension
    • Causes of Pulmonary Hypertension
    • PH vs. PAH
    • Diastolic Heart Failure vs. PAH
    • WHO Group 3 Pulmonary Hypertension, IPF & COPD
    • Pulmonary Veno-Occlusive Disease
    • Hereditary Hemorrhagic Telangiectasia (HHT)
      • Hereditary Hemorrhagic Telangiectasia (HHT) Treatment
    • Functional Classification of Pulmonary Hypertension
    • Congenital Heart Disease
      • Eisenmenger’s Syndrome
      • Update on Management of PAH-CHD
      • Congenital Heart Disease & Sleep Apnea
      • Complex Congenital Heart Disease
      • Atrial Septal Defect and Pulmonary Arterial Hypertension
    • Pediatric Pulmonary Arterial Hypertension
    • Sickle Cell and Pulmonary Hypertension
    • Stimulant Associated Pulmonary Arterial Hypertension
    • Porto-Pulmonary Syndrome
    • Research, Life Expectancy & Prognosis for PH
  • Diagnosing & Monitoring PAH
    • Pulmonary Arterial Hypertension Diagnosis
    • How Am I Doing? Assessing Your PAH.
    • Blood Tests
    • Cardiopulmonary Exercise Test (CPET)
    • CT (Computed Tomography) Scan
    • Echocardiogram: An Overview
    • Echocardiogram: A Detailed Look
    • Pulmonary Function Tests (PFTs)
    • Right Heart Catheterization
    • Six Minute Walk
    • Ventilation Perfusion Scan (VQ Scan)
    • CTEPH
      • CTEPH: WHO Group 4 Pulmonary Hypertension
      • PTE (Pulmonary Thromboendarterectomy) Surgery
      • Adempas used to Treat PAH and CTEPH
  • PAH Treatment
    • Pulmonary Hypertension Centers
    • Pulmonary Hypertension Treatments
    • Continuously Infused Therapies Used to Treat PH
    • Prostanoids for Treatment of PH
    • Adcirca and Revatio Used to Treat Pulmonary Arterial Hypertension (PAH)
    • Adempas used to Treat PAH and CTEPH
    • Tracleer, Letairis, and Opsumit Treatments
    • Oxygen Therapy for Pulmonary Hypertension
    • Salt and Water Restrictions
    • Exercise & PAH
    • Diuretics
    • Blood Thinners
    • Getting the Most Out of PAH Therapy
      • Letairis
      • Opsumit
      • Sildenafil (Revatio)
  • Research
  • FAQ’s
    • Implanted Remodulin Pump, Right Heart Catheterization, PAH & Pregnancy
    • Oral Treatments, Care Centers & Hole in Heart
    • FAQ’s: Altitude, Cold & Allergy Medications
    • FAQ’s: Psoriasis, Idiopathic PAH, Contraceptives & PAH
    • FAQ’s: Causes of Pulmonary Hypertension, Symptom Frequency & Care Centers
    • FAQ: PAH Experts, Pregnancy, Mild PAH & Vacationing
    • FAQ’s: CTEPH, Blood Clots, Corrective Surgery & PAH Care Centers
    • FAQ’s: VQ Scans & PAH Curable?
    • FAQ’s: Mild Pulmonary Hypertension?
    • FAQ’s: Boating, Swimming & Eating with PAH
    • FAQ’s: Borderline Pulmonary Hypertension, Hand Swelling, Children with PAH, Costs

Pulmonary Hypertension and Methamphetamines

June 14, 2019 By Dr. Jeremy Feldman

stimulant drugs associated with pulmonary arterial hypertension

Although the opioid epidemic is attracting more attention, there is another epidemic in America, methamphetamine abuse.  Methamphetamine (Meth) is an inexpensive drug that can be smoked, snorted or injected. It is made in a chemical reaction involving a common cold medicine.  Most Meth, however, is imported from Mexico.  Meth is extremely addicting.  Even casual use can lead to rapid addiction.  

Once ingested/injected/snorted, Meth travels to the brain and stimulates the reward center leading to a rapid “high”.  This is short lived and as the user comes down, they crave more drug.  

The cardiovascular (heart and lung) effects of Meth are very pronounced.  It leads to immediate increases in heart rate and blood pressure. Severe hypertension can lead to stroke and heart attack.  Irregular heart rhythms are common.  Prolonged use causes toxicity to the heart and can lead to irreversible heart failure.  In other users, Meth leads to severe pulmonary arterial hypertension. The drug is directly toxic to the pulmonary arteries causing intense vasoconstriction (squeezing of the pulmonary arteries).  Prolonged use leads to all of the classic changes of PAH.  The pulmonary arteries become thick and stiff. The right ventricle stops pumping, effectively causing heart failure and eventually patients develop liver and kidney failure as well.  

Many patients are embarrassed or ashamed about their drug use.  This can lead to delays in obtaining help or getting clean.  Detox programs are effective but require a motivated patient and supportive family.  First, the patient must decide that they are ready to kick the habit. Next they should have an honest discussion with their family and doctors.  Enlist the help of a program such as a 12-step program.  Perhaps the most important thing in getting clean is getting new friends.  Lose the phone numbers of your old friends.  These are the people that will drag you back into drug abuse.  Avoid situations where other people will be using. If you had a drinking problem, hanging out in a bar would be a bad plan.  The same goes for Meth.  Avoid parties or hanging out with friends that have drug problems.  

Be honest with your doctor. I have been to the rodeo too many times. My patients may think that I don’t know that they are using again but I do and your doctors probably do too. Drug dependence is a medical problem that can be treated.  Like any difficult medical problem it requires a motivated patient and the right treatment plan.  

There is no way to make your PAH better when you continue to use Meth.  You can take all the PAH meds on the market and you will still get worse if you continue to use Meth.  Your life will be so much better without Meth.  

Filed Under: Pulmonary Hypertension Diagnosis

PAH Life Expectancy

PAH Research

Research, Life Expectancy & Prognosis for PH

Major Developments in Pulmonary Hypertension Affecting Prognosis 1.     Approval of

Where to Get Treatment?

CCCs for PAH

Pulmonary Hypertension Centers

Where to get treatment for pulmonary hypertension? Pulmonary arterial hypertension is a

Popular Posts

Man swims with PAH

5 Benefits of Swimming

By Dr. Jeremy Feldman

Patients with pulmonary arterial hypertension often have a difficult time finding an exercise routine that works for

PAH Expert talking with PH patient

Orenitram Now Available To Treat PAH

By Dr. Jeremy Feldman

Orenitram (trepostinil), fondly referred to by some as oral Remodulin, was approved by the FDA to treat PAH in December

good news in pah

 

Disclaimer

Recent Blog Posts

  • In Memoriam:  Greg Ahearn, MD June 16, 2024
  • Sotatercept (Winrevair) Approved! June 1, 2024
  • Disappointing News for Rodatristat Ethyl October 11, 2023

Categories

Archives